The Logix Smart™ ABC (Influenza A/B, SARS-CoV-2) Test kit is an in vitro diagnostic test that uses our patented CoPrimer™ technology for the qualitative detection of the RNA from the Influenza A, Influenza B, and SARS-CoV-2 viruses.

The multiplex test operates using a single step real-time reverse transcriptase polymerase chain reaction (RT-PCR) process in lower respiratory tract specimens (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), upper respiratory tract specimens (e.g. nasopharyngeal, nasal, and oropharyngeal swabs), and saliva from individuals suspected of Influenza A, Influenza B or coronavirus disease 2019 (COVID-19) and its related conditions.

Click here to read the Company’s regulatory bulletin on the ability of our suite of Logix Smart COVID-19 diagnostics to detect all known strains of SARS-CoV-2.

Each Logix Smart ABC Test kit consists of the following components:

• Ready-to-use Master Mix, complete with internal positive control (human RNaseP) to verify sample and extraction quality

• Positive Control (PC), to verify the performance of the master mix and stability of components

• Nuclease-Free Water as a negative control, to verify master mix is free from contamination